CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2025	Mar. 30, 2024
Operating activities:
Net earnings	$ 246.7	$ 269.6
Adjustments to reconcile net earnings to net cash provided (used) by operating activities:
Depreciation	18.3	18.2
Amortization of other intangible assets	5.7	6.3
Provision for losses on finance receivables	18.2	18.2
Provision for losses on non-finance receivables	5.8	4.9
Stock-based compensation expense	4.5	9.8
Deferred income tax provision	3.7	1.6
Gain on sales of assets	0.0	(0.2)
Changes in operating assets and liabilities, net of effects of acquisitions:
Trade and other accounts receivable	(33.4)	(47.9)
Contract receivables	2.9	(4.0)
Inventories	(3.0)	22.1
Prepaid expenses and other assets	(9.4)	(3.5)
Accounts payable	18.5	23.3
Accrued and other liabilities	20.0	30.3
Net cash provided by operating activities	298.5	348.7
Investing activities:
Additions to finance receivables	(218.9)	(248.0)
Collections of finance receivables	210.7	207.8
Capital expenditures	(22.9)	(21.8)
Disposals of property and equipment	0.1	1.1
Other	(1.0)	(2.3)
Net cash used by investing activities	(32.0)	(63.2)
Financing activities:
Net increase (decrease) in other short-term borrowings	4.5	(0.4)
Cash dividends paid	(112.2)	(98.2)
Purchases of treasury stock	(87.2)	(70.2)
Proceeds from stock purchase plans and stock option exercises	18.3	28.3
Other	(17.0)	(23.7)
Net cash used by financing activities	(193.6)	(164.2)
Effect of exchange rate changes on cash and cash equivalents	1.5	(1.8)
Increase in cash and cash equivalents	74.4	119.5
Cash and cash equivalents at beginning of year	1,360.5	1,001.5
Cash and cash equivalents at end of period	1,434.9	1,121.0
Supplemental cash flow disclosures:
Cash paid for interest	(13.6)	(13.7)
Net cash paid for income taxes	$ (19.8)	$ (14.7)